2021
Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications
Ghovanloo MR, Ruben PC. Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications. The Neuroscientist 2021, 28: 318-334. PMID: 34027742, PMCID: PMC9344566, DOI: 10.1177/10738584211017009.Peer-Reviewed Original ResearchConceptsClinical implicationsNav channelsPotential therapeutic meansInteractions of cannabidiolVoltage-gated sodiumSodium channel pharmacologyClinical syndromePreclinical studiesCBD useNeurological conditionsCBD interactionsChannel pharmacologyTherapeutic meansAction potentialsMuscular problemsPathophysiological conditionsCannabidiolChannel functionExcitable tissuesViable compoundCannabis plantTissueDifferent tissuesHyperexcitabilitySyndrome
2016
Chapter Fifteen Physiology and Pathophysiology of Sodium Channel Inactivation
Ghovanloo MR, Aimar K, Ghadiry-Tavi R, Yu A, Ruben PC. Chapter Fifteen Physiology and Pathophysiology of Sodium Channel Inactivation. Current Topics In Membranes 2016, 78: 479-509. PMID: 27586293, DOI: 10.1016/bs.ctm.2016.04.001.Peer-Reviewed Original Research